Trexquant Investment LP Amphastar Pharmaceuticals, Inc. Put Options Transaction History
Trexquant Investment LP
- $8.06 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AMPH
# of Institutions
275Shares Held
35.1MCall Options Held
56.2KPut Options Held
3.5K-
Black Rock Inc. New York, NY5.94MShares$189 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$86.2 Million0.0% of portfolio
-
Td Asset Management Inc1.84MShares$58.4 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$50.7 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.37MShares$43.6 Million0.04% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.56B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...